Pharmaxis Ltd - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for Pharmaxis Ltd. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

Pharmaxis Ltd. The Group's principal activities are researching, developing and commercializing human healthcare products for the treatment and management of chronic respiratory and immune disease. Products include Aridol and Bronchitol. Aridol is designed to help doctors diagnose and manage asthma by detecting active airway inflammation through measuring airway hyper-responsiveness. Bronchitol is a drug designed to reduce the amount of mucus build-up in the lungs of patients suffering from chronic respiratory conditions. The Group operates predominantly in Australia.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report